News + Filings Transactions
|
Burgess Paul D.
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/04/2023 | Cerevel Therapeutics Holdings, Inc. | CERE | Purchase | Common Stock | 21.9k | $22.93 | $501.8k | | 08/04/2023 |
| 07/03/2023 | Cerevel Therapeutics Holdings, Inc. | CERE | Grant | Stock Option (Right to Buy) | 95.9k | $31.45 | $3M | | 07/03/2023 |
| 07/03/2023 | Cerevel Therapeutics Holdings, Inc. | CERE | Grant | Restricted Stock Units | 23.8k | $0.00 | $0 | | 07/03/2023 |
| 09/14/2021 | Translate Bio, Inc. | TBIO | Sale | Stock Option (right to buy) | 90k | $23.82 | $2.1M | | 09/14/2021 |
| 09/14/2021 | Translate Bio, Inc. | TBIO | Sale | Stock Option (right to buy) | 150k | $7.66 | $1.1M | | 09/14/2021 |
| 09/14/2021 | Translate Bio, Inc. | TBIO | Sale | Stock Option (right to buy) | 150k | $7.95 | $1.2M | | 09/14/2021 |
| 09/14/2021 | Translate Bio, Inc. | TBIO | Sale | Stock Option (right to buy) | 70k | $8.34 | $583.4k | | 09/14/2021 |
| 09/14/2021 | Translate Bio, Inc. | TBIO | Sale | Stock Option (right to buy) | 219.7k | $7.39 | $1.6M | | 09/14/2021 |
| 09/14/2021 | Translate Bio, Inc. | TBIO | Sale | Common Stock | 71.8k | $38.00 | $2.7M | | 09/14/2021 |
| 03/09/2021 | Translate Bio, Inc. | TBIO | Grant | Stock Option (right to buy) | 90k | $23.82 | $2.1M | | 03/09/2021 |
| 03/03/2020 | Translate Bio, Inc. | TBIO | Grant | Stock Option (right to buy) | 150k | $7.66 | $1.1M | | 03/03/2020 |
| 03/08/2019 | Translate Bio, Inc. | TBIO | Grant | Stock Option (right to buy) | 150k | $7.95 | $1.2M | | 03/08/2019 |
|